List of Figures:
Figure 2-1: Global - Leading Causes of Death (%), 2005E
Figure 2-2: Global - New Cancer Cases* (in Million), 2002, 2007, 2012F & 2020F
Figure 2-3: Global - New Cancer Cases* in Males by Type (%), 2007E
Figure 2-4: Global - New Cancer Cases* in Females by Type (%), 2007E
Figure 2-5: Global - New Cancer Cases by Region (in Number), 2007E
Figure 2-6: Global - Leading Causes of Cancer (%)
Figure 3-1: Global - Cancer Market (in Billion US$), 2007-2012F
Figure 3-2: Global - Cancer Market by Drug Type (%), 2007
Figure 3-3: Global - Forecast for Cancer Market by Drug Type (%), 2012
Figure 3-4: Global - Drugs under Clinical Development by Therapy Area (%), 2007
Figure 3-5: Global - Cancer Drugs by Type in Phase-II Clinical Development Process (%), 2006
Figure 3-6: Global - Cancer Drugs by Type in Phase-III Clinical Development Process (%), 2006
Figure 3-7: Global - In-licensing Deals by Therapy Area (%), 2006
Figure 4-1: Global - Chemotherapy Market (in Million US$), 2007-2012F
Figure 4-2: Global - Plant Alkaloids Market (in Million US$), 2007-2012F
Figure 4-3: Global - Alkylation Agents Market (in Million US$), 2007-2012F
Figure 4-4: Global - Anti-metabolites Market (in Million US$), 2007-2012F
Figure 4-5: Global - Platinum Compounds Market (in Million US$), 2007-2012F
Figure 4-6: Global - Cytotoxic Antibiotics Market (in Million US$), 2007-2012F
Figure 4-7: Global - Other Cytostatics Market (in Million US$), 2007-2012F
Figure 4-8: Global - Antiangiogenics Market (in Million US$), 2007-2012F
Figure 4-9: Global - Hormone Therapy Market for Cancer Treatment (in Million US$) 2007-2012F
Figure 4-10: Global - Hormone Therapy Market Segmentation for Cancer Treatment (%), 2004 & 2014F
Figure 4-11: Global - Monoclonal Antibodies Market (in Million US$), 2007-2012F
Figure 4-12: Global - Cancer Vaccine Market (in Million US$), 2006, 2007E & 2012F
Figure 4-13: Global - Cancer Vaccine by Type in various Phases of Clinical Development (in Number), Aug 2005
Figure 5-1: US - New Cancer Cases* (in Number), 2005, 2008F & 2012F
Figure 5-2: US - Cancer Market (in Million US$) 1999, 2004, 2007E & 2012F
Figure 5-3: US - Cancer Market by Therapy Area (%) 1999, 2004, 2007E & 2012F
Figure 5-4: Europe - New Cancer Cases* (in Number), 2004, 2006 & 2012F
Figure 5-5: Europe - Cancer Market (in Billion US$), 2004, 2007E & 2012F
Figure 5-6: Japan - Cancer Market (in Billion US$), 2005, 2007E & 2012F
Figure 5-7: India - New & Total Number of Cancer Patients (in Million)
Figure 5-8: China - New & Total Number of Cancer Patients (in Million)
Figure 5-9: India - Cancer Market (in Million US$), 2007 & 2012F
Figure 6-1: Global - Cancer Drug Delivery Market (in Billion US$), 2005E, 2010F & 2015F
Figure 6-2: Global - Cancer Diagnostics Market (in Billion US$), 2002, 2007E & 2012F
Figure 6-3: Global* - Cancer Drugs going Off-patent (in Billion US$), 2008-2014
Figure 6-4: Global* - Cancer Generic Market (in Billion US$), 2004, 2005, 2007E & 2014F
Figure 6-5: Global* - Cancer Generic Market by Country (%), 2005
Figure 7-1: Success Rates of Drugs by Therapy Area from First in Man to Registration (%)
List of Tables:
Table 2-1: Global - New Cancer Cases* in Males by Type (in Number), 2007E
Table 2-2: Global - New Cancer Cases* in Females by Type (in Number), 2007E
Table 3-1: Global - Revenues from Major Therapy Areas (in Million US$), 2007 & 2012F
Table 3-2: Global - Growth of various Cancer Drugs (%), 2007-2012
Table 3-3: Global - Sales of Top Companies in Cancer Market* (in Million US$), 2007
Table 3-4: Global - Forecast for Sales of Top Companies in Cancer Market* (in Million US$), 2012
Table 3-5: Global - Sales* of Top Cancer Drugs (in Billion US$), 2002
Table 3-6: Global - Sales* of Top Cancer Drugs (in Billion US$), 2006
Table 3-7: Global - Forecast for Sales* of Top Cancer Drugs (in Billion US$), 2012
Table 5-1: US - New Cancer Cases* for Selected Cancer Sites (in Number), 2008F
Table 5-2: US - Key Players in the Cancer Market by Rank (2000 & 2005)
Table 5-3: Europe - New Cancer Cases in Top 5 Countries (in ‘000), 2006
Table 5-4: Japan - Leading Sites of Cancer Incidences in Males & Females (%), 2001
Table 6-1: Global - Cancer Diagnostics Market by Type of Test (in Million US$), 2002-2006E
